Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ana Gleisner

Concepts (331)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatectomy
38
2025
211
5.200
 Why?
Liver Neoplasms
38
2025
643
5.170
 Why?
Carcinoma, Hepatocellular
23
2025
271
4.600
 Why?
Pancreatic Neoplasms
24
2024
878
4.220
 Why?
Adenocarcinoma
25
2024
889
3.680
 Why?
Sentinel Lymph Node
8
2022
42
2.870
 Why?
Laparoscopy
9
2024
454
2.570
 Why?
Melanoma
12
2022
752
2.500
 Why?
Skin Neoplasms
12
2022
834
2.430
 Why?
Pancreaticoduodenectomy
11
2024
159
2.280
 Why?
Cholangiocarcinoma
10
2025
77
2.210
 Why?
Bile Duct Neoplasms
10
2025
99
2.120
 Why?
Lymph Node Excision
11
2024
165
2.100
 Why?
Pancreatectomy
7
2024
243
1.910
 Why?
Neoplasm Recurrence, Local
16
2025
963
1.700
 Why?
Postoperative Complications
18
2025
2496
1.690
 Why?
Sentinel Lymph Node Biopsy
11
2023
108
1.570
 Why?
Minimally Invasive Surgical Procedures
6
2025
174
1.500
 Why?
Retrospective Studies
75
2025
14571
1.290
 Why?
Survival Rate
32
2025
1875
1.290
 Why?
Tumor Burden
10
2025
283
1.170
 Why?
Databases, Factual
16
2025
1279
1.070
 Why?
Aged
72
2025
22090
1.060
 Why?
Prognosis
35
2025
3788
1.030
 Why?
Liver Transplantation
11
2024
799
0.990
 Why?
Lymph Nodes
8
2024
467
0.980
 Why?
Middle Aged
81
2025
31080
0.940
 Why?
Esophagectomy
4
2021
124
0.930
 Why?
Robotic Surgical Procedures
3
2019
110
0.880
 Why?
Esophageal Neoplasms
7
2023
293
0.870
 Why?
Lymphatic Metastasis
12
2025
318
0.850
 Why?
Conversion to Open Surgery
2
2020
15
0.840
 Why?
Thrombelastography
1
2024
148
0.840
 Why?
Breast Neoplasms
5
2024
2150
0.830
 Why?
Nomograms
2
2022
47
0.820
 Why?
Colorectal Neoplasms
9
2025
753
0.790
 Why?
Carcinoma, Pancreatic Ductal
5
2023
266
0.780
 Why?
Bilirubin
4
2025
92
0.750
 Why?
Humans
122
2025
129136
0.740
 Why?
Rectal Neoplasms
5
2023
136
0.740
 Why?
Female
92
2025
68519
0.720
 Why?
Risk Assessment
15
2025
3260
0.720
 Why?
Male
88
2025
63203
0.700
 Why?
Colonic Neoplasms
3
2024
242
0.620
 Why?
Serum Albumin
5
2025
145
0.610
 Why?
Quality of Life
2
2019
2694
0.570
 Why?
Head and Neck Neoplasms
6
2019
535
0.550
 Why?
Follow-Up Studies
18
2025
4915
0.550
 Why?
Metastasectomy
3
2024
21
0.540
 Why?
Treatment Outcome
26
2025
10227
0.520
 Why?
Neoadjuvant Therapy
11
2023
381
0.520
 Why?
Peritoneal Neoplasms
3
2024
87
0.520
 Why?
Neoplasm Staging
10
2023
1293
0.510
 Why?
Colectomy
3
2013
94
0.500
 Why?
Machine Learning
3
2025
447
0.490
 Why?
Liver Failure
3
2009
91
0.460
 Why?
Stomach Neoplasms
2
2024
98
0.430
 Why?
Axilla
3
2023
43
0.420
 Why?
Cytoreduction Surgical Procedures
3
2024
61
0.410
 Why?
Decision Making
1
2019
851
0.400
 Why?
Propensity Score
4
2024
265
0.390
 Why?
Aged, 80 and over
18
2024
7066
0.370
 Why?
Ampulla of Vater
2
2024
38
0.360
 Why?
Predictive Value of Tests
6
2025
1943
0.360
 Why?
Decision Support Techniques
2
2025
405
0.350
 Why?
Length of Stay
6
2025
1124
0.350
 Why?
ROC Curve
5
2025
502
0.340
 Why?
alpha-Fetoproteins
3
2025
39
0.340
 Why?
Neuroendocrine Tumors
2
2023
99
0.320
 Why?
Benchmarking
2
2021
176
0.320
 Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
10
0.310
 Why?
Gallbladder Neoplasms
2
2024
20
0.300
 Why?
Adult
35
2025
35513
0.300
 Why?
Margins of Excision
4
2023
38
0.290
 Why?
CA-19-9 Antigen
2
2024
22
0.280
 Why?
Risk Factors
14
2025
9769
0.280
 Why?
Mastectomy, Segmental
2
2017
85
0.280
 Why?
Disease-Free Survival
8
2024
656
0.270
 Why?
Liver Cirrhosis
4
2025
275
0.260
 Why?
Catheter Ablation
2
2008
332
0.250
 Why?
Survival Analysis
7
2024
1265
0.250
 Why?
Hyperglycemia
2
2020
326
0.240
 Why?
Infusions, Intra-Arterial
1
2025
54
0.240
 Why?
Time Factors
8
2025
6518
0.240
 Why?
gamma-Glutamyltransferase
1
2025
40
0.240
 Why?
Hepatic Artery
1
2025
58
0.240
 Why?
Medical Futility
1
2025
24
0.240
 Why?
United States
16
2024
13941
0.240
 Why?
Anastomotic Leak
1
2024
38
0.230
 Why?
Blood Loss, Surgical
1
2025
91
0.230
 Why?
Abdomen, Acute
1
2004
18
0.230
 Why?
Quality Indicators, Health Care
2
2025
297
0.230
 Why?
Cohort Studies
10
2023
5407
0.220
 Why?
Preoperative Care
3
2024
342
0.220
 Why?
Bacterial Infections
3
2006
229
0.220
 Why?
Chemotherapy, Adjuvant
6
2025
376
0.220
 Why?
Lymphopenia
1
2024
59
0.220
 Why?
Combined Modality Therapy
6
2024
1209
0.210
 Why?
Odds Ratio
4
2019
1025
0.210
 Why?
Practice Guidelines as Topic
2
2024
1493
0.210
 Why?
SEER Program
2
2014
206
0.210
 Why?
Time-to-Treatment
1
2024
180
0.210
 Why?
Multilocus Sequence Typing
1
2022
13
0.210
 Why?
Lymphoscintigraphy
2
2019
9
0.200
 Why?
Lung Neoplasms
3
2023
2329
0.200
 Why?
Surgical Oncology
1
2022
22
0.200
 Why?
Sunburn
1
2002
26
0.200
 Why?
Sunscreening Agents
1
2002
23
0.200
 Why?
Mastectomy
1
2023
131
0.200
 Why?
Nevus, Pigmented
1
2002
33
0.200
 Why?
Pelvic Exenteration
2
2019
11
0.200
 Why?
Klatskin Tumor
1
2021
14
0.190
 Why?
Anesthetics, Inhalation
1
2021
17
0.190
 Why?
Artificial Intelligence
1
2024
248
0.180
 Why?
Propofol
1
2021
54
0.180
 Why?
Chemoradiotherapy
4
2023
209
0.180
 Why?
Prospective Studies
8
2022
7079
0.170
 Why?
Organ Preservation
4
2023
92
0.170
 Why?
Hyperthermia, Induced
2
2020
109
0.170
 Why?
Proportional Hazards Models
3
2025
1210
0.170
 Why?
Registries
2
2021
1884
0.170
 Why?
Reoperation
3
2017
560
0.160
 Why?
Scalp
1
2019
35
0.160
 Why?
Kaplan-Meier Estimate
3
2025
864
0.160
 Why?
Anesthesia
1
2021
130
0.160
 Why?
Regression Analysis
2
2019
984
0.160
 Why?
Inflammation
3
2024
2668
0.160
 Why?
Pancreatic Diseases
1
2019
67
0.160
 Why?
Neutrophils
1
2024
1195
0.160
 Why?
Skin Pigmentation
1
2019
48
0.150
 Why?
Referral and Consultation
1
2024
732
0.150
 Why?
Tomography, X-Ray Computed
3
2025
2541
0.150
 Why?
Population Surveillance
1
2021
428
0.140
 Why?
Patient Acceptance of Health Care
1
2024
767
0.140
 Why?
Appendiceal Neoplasms
1
2017
26
0.140
 Why?
Common Bile Duct Neoplasms
1
2017
27
0.140
 Why?
Patient Compliance
1
2021
562
0.140
 Why?
Neoplasms
2
2022
2476
0.140
 Why?
Gastric Outlet Obstruction
1
2017
9
0.140
 Why?
Pylorus
1
2017
18
0.140
 Why?
Waiting Lists
2
2009
238
0.140
 Why?
Carcinoma, Ductal, Breast
1
2017
82
0.140
 Why?
Disease Management
1
2021
593
0.140
 Why?
Radiotherapy, Intensity-Modulated
1
2018
128
0.140
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1573
0.130
 Why?
Hospitals, High-Volume
1
2016
39
0.130
 Why?
Cancer Care Facilities
1
2016
31
0.130
 Why?
Nutritional Status
1
2019
327
0.130
 Why?
Neuromuscular Agents
1
2017
30
0.130
 Why?
Botulinum Toxins, Type A
1
2017
40
0.130
 Why?
Hospitals
1
2021
632
0.130
 Why?
Genital Neoplasms, Female
1
2017
81
0.130
 Why?
Patient Reported Outcome Measures
1
2019
369
0.130
 Why?
Cannabis
1
2023
436
0.130
 Why?
Tomography, Emission-Computed, Single-Photon
1
2016
78
0.130
 Why?
Adenoma
1
2017
215
0.120
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
1046
0.120
 Why?
Radiosurgery
1
2018
318
0.120
 Why?
Anti-Bacterial Agents
1
2004
1671
0.110
 Why?
Phenotype
1
2002
3058
0.110
 Why?
Patient Readmission
1
2019
668
0.110
 Why?
Antineoplastic Agents
3
2021
2062
0.110
 Why?
Delivery of Health Care
1
2021
894
0.110
 Why?
Hospital Mortality
4
2024
844
0.110
 Why?
Morbidity
4
2021
302
0.110
 Why?
Unnecessary Procedures
1
2014
48
0.110
 Why?
Trauma Centers
2
2014
410
0.110
 Why?
Abdomen
1
2013
117
0.100
 Why?
Radiation Dosage
1
2014
153
0.100
 Why?
Clinical Competence
1
2019
1021
0.100
 Why?
Renal Insufficiency
1
2013
148
0.090
 Why?
Asia
2
2021
58
0.090
 Why?
Triage
1
2012
213
0.090
 Why?
Carcinoma, Renal Cell
1
2012
180
0.080
 Why?
Age Factors
4
2022
3120
0.080
 Why?
Europe
2
2021
362
0.080
 Why?
Logistic Models
2
2025
1979
0.080
 Why?
Kidney Transplantation
2
2013
605
0.080
 Why?
Organ Preservation Solutions
2
2006
43
0.080
 Why?
Brain Injuries
1
2014
468
0.080
 Why?
Graft Survival
2
2009
505
0.080
 Why?
Diagnostic Tests, Routine
2
2024
103
0.080
 Why?
Practice Patterns, Physicians'
1
2017
1270
0.080
 Why?
Laparotomy
1
2008
109
0.070
 Why?
Bile Ducts, Extrahepatic
1
2008
22
0.070
 Why?
Kidney Neoplasms
1
2012
350
0.070
 Why?
Biliary Tract Surgical Procedures
1
2008
25
0.070
 Why?
Case-Control Studies
2
2007
3342
0.070
 Why?
Neoplasm Invasiveness
3
2020
480
0.070
 Why?
Intraoperative Care
1
2007
45
0.070
 Why?
Cholangitis, Sclerosing
1
2008
70
0.070
 Why?
Young Adult
7
2022
12389
0.070
 Why?
Electrocoagulation
1
2007
38
0.070
 Why?
Anus Neoplasms
1
2007
30
0.070
 Why?
Congenital Hypothyroidism
1
1986
11
0.070
 Why?
Guideline Adherence
2
2024
525
0.070
 Why?
Brazil
2
2008
154
0.070
 Why?
Multivariate Analysis
2
2025
1496
0.070
 Why?
Ultrasonography, Interventional
1
2007
128
0.070
 Why?
Fluorouracil
2
2022
197
0.060
 Why?
Wounds and Injuries
1
2012
719
0.060
 Why?
Mycophenolic Acid
1
2006
92
0.060
 Why?
Pandemics
2
2023
1492
0.060
 Why?
Adolescent
9
2022
20302
0.060
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
26
0.060
 Why?
Serum Albumin, Human
1
2024
5
0.060
 Why?
Platelet Count
1
2024
82
0.060
 Why?
Sample Size
1
2025
115
0.060
 Why?
Severity of Illness Index
2
2009
2739
0.060
 Why?
Lymphocyte Count
1
2024
151
0.060
 Why?
Radiotherapy, Adjuvant
2
2019
211
0.060
 Why?
Zygomycosis
1
2003
6
0.060
 Why?
Gastrectomy
1
2024
99
0.050
 Why?
Bile Ducts, Intrahepatic
1
2024
65
0.050
 Why?
Developmental Disabilities
1
1986
257
0.050
 Why?
Cluster Analysis
1
2025
479
0.050
 Why?
Comorbidity
2
2022
1547
0.050
 Why?
Antibiotic Prophylaxis
1
2004
95
0.050
 Why?
Hepatocytes
1
2004
213
0.050
 Why?
Lymphocytes
1
2024
369
0.050
 Why?
Appendicitis
1
2004
132
0.050
 Why?
Biology
1
2023
83
0.050
 Why?
Capecitabine
1
2022
47
0.050
 Why?
Pneumonectomy
1
2023
150
0.050
 Why?
Carcinoma, Squamous Cell
1
2007
621
0.050
 Why?
Anesthesia, Intravenous
1
2021
11
0.050
 Why?
Anesthetics, Intravenous
1
2021
38
0.050
 Why?
Surgical Wound Infection
1
2004
283
0.040
 Why?
Esophagogastric Junction
1
2021
50
0.040
 Why?
Models, Biological
1
2008
1695
0.040
 Why?
Induction Chemotherapy
1
2021
70
0.040
 Why?
Body Mass Index
2
2024
2266
0.040
 Why?
Liver
2
2006
1833
0.040
 Why?
Thoracoscopy
1
2020
51
0.040
 Why?
Medical Oncology
1
2022
274
0.040
 Why?
Societies, Medical
1
2024
749
0.040
 Why?
Image-Guided Biopsy
1
2019
37
0.040
 Why?
Adenocarcinoma, Mucinous
1
2020
75
0.040
 Why?
Preoperative Period
1
2019
113
0.040
 Why?
Biomarkers, Tumor
1
2024
1185
0.040
 Why?
Oxidative Stress
1
2004
1192
0.040
 Why?
Perioperative Period
1
2017
48
0.040
 Why?
Carcinoma, Lobular
1
2017
48
0.030
 Why?
Occipital Bone
1
2017
19
0.030
 Why?
Operative Time
1
2017
122
0.030
 Why?
Parotid Gland
1
2017
21
0.030
 Why?
Gastric Emptying
1
2017
38
0.030
 Why?
Obesity
1
2010
2863
0.030
 Why?
Health Behavior
1
2002
741
0.030
 Why?
Longitudinal Studies
1
2024
2716
0.030
 Why?
Neck
1
2017
92
0.030
 Why?
Perioperative Care
1
2018
149
0.030
 Why?
Sex Factors
1
2022
1953
0.030
 Why?
Raffinose
2
2006
21
0.030
 Why?
Allopurinol
2
2006
61
0.030
 Why?
Glucose
1
2020
983
0.030
 Why?
Consensus
1
2017
638
0.030
 Why?
Adenosine
2
2006
211
0.030
 Why?
Glutathione
2
2006
334
0.030
 Why?
Drug Administration Schedule
1
2015
758
0.030
 Why?
Cross-Sectional Studies
2
2022
5070
0.030
 Why?
Glasgow Coma Scale
1
2014
170
0.030
 Why?
Magnetic Resonance Imaging
1
2025
3383
0.030
 Why?
Radiation Injuries
1
2014
137
0.030
 Why?
Vital Signs
1
2012
41
0.030
 Why?
Incidence
1
2019
2635
0.030
 Why?
New South Wales
1
2012
14
0.030
 Why?
Child
6
2014
20806
0.020
 Why?
Baltimore
1
2012
44
0.020
 Why?
Disease Progression
1
2020
2613
0.020
 Why?
Italy
1
2012
98
0.020
 Why?
Child, Preschool
4
2014
10451
0.020
 Why?
Hospital Costs
1
2012
117
0.020
 Why?
Pharmaceutical Preparations
1
2013
170
0.020
 Why?
Biological Therapy
1
2011
29
0.020
 Why?
Albuminuria
1
1992
181
0.020
 Why?
Chi-Square Distribution
1
2012
513
0.020
 Why?
Injury Severity Score
1
2012
518
0.020
 Why?
Lung
1
2023
3753
0.020
 Why?
Surveys and Questionnaires
1
2022
5377
0.020
 Why?
Glomerular Filtration Rate
1
2013
682
0.020
 Why?
Immunosuppressive Agents
1
2013
690
0.020
 Why?
Infant, Newborn
2
2014
5739
0.020
 Why?
Carcinoembryonic Antigen
1
2008
41
0.020
 Why?
Antimetabolites, Antineoplastic
1
2008
90
0.020
 Why?
Radiopharmaceuticals
1
2008
166
0.020
 Why?
Fluorodeoxyglucose F18
1
2008
127
0.020
 Why?
Sensitivity and Specificity
1
2012
1825
0.020
 Why?
Infant
3
2014
8993
0.020
 Why?
Colorado
1
2017
4396
0.020
 Why?
Retreatment
1
2007
70
0.020
 Why?
Cholecystectomy
1
2007
59
0.020
 Why?
Positron-Emission Tomography
1
2008
283
0.020
 Why?
Incidental Findings
1
2007
80
0.020
 Why?
Neoplasm, Residual
1
2007
119
0.020
 Why?
Biopsy, Needle
1
2007
189
0.020
 Why?
Tablets, Enteric-Coated
1
2006
3
0.020
 Why?
Hepatitis B
1
2007
61
0.020
 Why?
Histidine
1
2006
58
0.020
 Why?
Radiography
1
2008
865
0.020
 Why?
Psychological Tests
1
1986
132
0.020
 Why?
Overweight
1
2010
526
0.020
 Why?
Graft Rejection
1
2009
558
0.020
 Why?
Tryptophan
1
2006
169
0.010
 Why?
Insulin
2
2006
2320
0.010
 Why?
Glutathione Disulfide
1
2004
31
0.010
 Why?
Hepatitis C
1
2007
234
0.010
 Why?
Sulfamethoxypyridazine
1
1983
1
0.010
 Why?
Trimethoprim
1
1983
7
0.010
 Why?
Gastrointestinal Diseases
1
2006
197
0.010
 Why?
Liver Function Tests
1
2004
109
0.010
 Why?
Anti-Infective Agents, Urinary
1
1983
13
0.010
 Why?
Amphotericin B
1
2003
30
0.010
 Why?
Liver Diseases
1
2006
285
0.010
 Why?
Patient Selection
1
2007
665
0.010
 Why?
Antifungal Agents
1
2003
126
0.010
 Why?
Cause of Death
1
2004
393
0.010
 Why?
Immunocompromised Host
1
2003
195
0.010
 Why?
Urinary Tract Infections
1
1983
150
0.010
 Why?
Reperfusion Injury
1
2004
263
0.010
 Why?
Cardiovascular Diseases
1
1992
2024
0.010
 Why?
Diabetes Mellitus, Type 1
1
1992
3624
0.010
 Why?
Cholesterol
1
1992
406
0.010
 Why?
Blood Pressure
1
1992
1735
0.000
 Why?
Sulfamethoxazole
1
1983
7
0.000
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1983
39
0.000
 Why?
Escherichia coli Infections
1
1983
106
0.000
 Why?
Drug Combinations
1
1983
329
0.000
 Why?
Microbial Sensitivity Tests
1
1983
336
0.000
 Why?
Escherichia coli
1
1983
771
0.000
 Why?
Clinical Trials as Topic
1
1983
1000
0.000
 Why?
Gleisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (331) concept(s)
_
Co-Authors Expand Description
See all (43) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)